Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase II trial of alternating osimertinib with gefitinib in patients with EGFR-T790M mutation positive advanced non-small cell lung cancer (Oscillate)

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY(2018)

Cited 0|Views12
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined